Works matching IS 13419625 AND DT 2024 AND VI 29 AND IP 5


Results: 15
    1

    Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 559, doi. 10.1007/s10147-024-02501-7
    By:
    • Kimura, Shoji;
    • Shigeta, Keisuke;
    • Tamura, Shingo;
    • Uchino, Keita;
    • Kimura, Takahiro;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio
    Publication type:
    Article
    2
    3

    Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 551, doi. 10.1007/s10147-024-02499-y
    By:
    • Ozaki, Yukinori;
    • Yokoe, Takamichi;
    • Yoshinami, Tetsuhiro;
    • Nozawa, Kazuki;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miura, Yuji;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita;
    • Kimura, Takahiro
    Publication type:
    Article
    4

    Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 512, doi. 10.1007/s10147-024-02497-0
    By:
    • Kikuchi, Yoshinori;
    • Shimada, Hideaki;
    • Yamasaki, Fumiyuki;
    • Yamashita, Taku;
    • Araki, Koji;
    • Horimoto, Kohei;
    • Yajima, Satoshi;
    • Yashiro, Masakazu;
    • Yokoi, Keigo;
    • Cho, Haruhiko;
    • Ehira, Takuya;
    • Nakahara, Kazunari;
    • Yasuda, Hiroshi;
    • Isobe, Kazutoshi;
    • Hayashida, Tetsu;
    • Hatakeyama, Shingo;
    • Akakura, Koichiro;
    • Aoki, Daisuke;
    • Nomura, Hiroyuki;
    • Tada, Yuji
    Publication type:
    Article
    5
    6

    Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 545, doi. 10.1007/s10147-024-02491-6
    By:
    • Uchino, Keita;
    • Tamura, Shingo;
    • Kimura, Shoji;
    • Shigeta, Keisuke;
    • Kimura, Takahiro;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Endo, Makoto;
    • Yano, Shingo;
    • Maruyama, Dai;
    • Yoshinami, Tetsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio
    Publication type:
    Article
    7
    8
    9
    10
    11

    An approach for improvement of the accuracy of cancer gene panel testing.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 571, doi. 10.1007/s10147-024-02483-6
    By:
    • Imoto, Kiyomi;
    • Yamamoto, Hiroyuki;
    • Ohkawa, Chie;
    • Shimada, Naoki;
    • Ikuzawa, Ryo;
    • Takeda, Hiroyuki;
    • Ohhara, Tatsuru;
    • Kojima, Yasuyuki;
    • Furuya, Naoki;
    • Motoyoshi, Ai;
    • Migita, Ohsuke;
    • Kuga, Asami;
    • Keira, Takayuki;
    • Wakamatsu, Hirotake;
    • Sato, Tomoo;
    • Oike, Nobuyuki;
    • Koike, Junki;
    • Yamano, Yoshihisa;
    • Sunakawa, Yu
    Publication type:
    Article
    12

    Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 612, doi. 10.1007/s10147-024-02482-7
    By:
    • Hashimoto, Masaki;
    • Fukuokaya, Wataru;
    • Yanagisawa, Takafumi;
    • Yamamoto, Shutaro;
    • Koike, Yuhei;
    • Imai, Yu;
    • Iwatani, Kosuke;
    • Onuma, Hajime;
    • Ito, Kagenori;
    • Urabe, Fumihiko;
    • Tsuzuki, Shunsuke;
    • Kimura, Shoji;
    • Oyama, Yu;
    • Abe, HIrokazu;
    • Miki, Jun;
    • Kimura, Takahiro
    Publication type:
    Article
    13

    Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 602, doi. 10.1007/s10147-024-02481-8
    By:
    • Taoka, Rikiya;
    • Kamada, Masaki;
    • Izumi, Kazuyoshi;
    • Tanimoto, Ryuta;
    • Daizumoto, Kei;
    • Hayashida, Yushi;
    • Uematsu, Katsutoshi;
    • Arai, Hironobu;
    • Sano, Takeshi;
    • Saito, Ryoichi;
    • Hirama, Hiromi;
    • Kobayashi, Toshihiro;
    • Honda, Tomoko;
    • Osaki, Yu;
    • Abe, Yohei;
    • Naito, Hirohito;
    • Tohi, Yoichiro;
    • Matsuoka, Yuki;
    • Kato, Takuma;
    • Okazoe, Homare
    Publication type:
    Article
    14

    Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 5, p. 535, doi. 10.1007/s10147-023-02465-0
    By:
    • Maeda, Tomoya;
    • Najima, Yuho;
    • Kamiyama, Yutaro;
    • Nakao, Shinji;
    • Ozaki, Yukinori;
    • Nishio, Hiroshi;
    • Tsuchihashi, Kenji;
    • Ichihara, Eiki;
    • Miumra, Yuji;
    • Endo, Makoto;
    • Maruyama, Dai;
    • Yoshinami, Tatsuhiro;
    • Susumu, Nobuyuki;
    • Takekuma, Munetaka;
    • Motohashi, Takashi;
    • Ito, Mamoru;
    • Baba, Eishi;
    • Ochi, Nobuaki;
    • Kubo, Toshio;
    • Uchino, Keita
    Publication type:
    Article
    15